BML Capital Management, LLC Q4 2025 Filing

Filed February 3, 2026

Portfolio Value

$115.7B

Holdings

16

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (16 positions)

#StockSharesValue% PortfolioType
1
ACRSACLARIS THERAPEUTICS INC
14,250,000$42.9B37.08%
2
AVIRATEA PHARMACEUTICALS INC
7,490,000$26.7B23.11%
3
ORMPORAMED PHARMACEUTICALS INC
3,167,231$9.0B7.80%
4
TILINSTIL BIO INC
645,600$7.1B6.14%
5
PMVPPMV PHARMACEUTICALS INC
5,292,000$6.6B5.72%
6
KMXCARMAX INC
155,000$6.0B5.18%
7
KZRKEZAR LIFE SCIENCES INC
720,787$4.5B3.92%
8
DYHTARGET CORP
37,500$3.7B3.17%
9
CVNACARVANA CO
150$2.0B1.74%Put
10
OMOUTSET MED INC
543,180$2.0B1.74%
11
PLRXPLIANT THERAPEUTICS INC
1,546,137$1.9B1.63%
12
IMAIMAGENEBIO INC
177,026$1.2B1.06%
13
CNTBCONNECT BIOPHARMA HLDGS LTD
408,887$1.2B1.00%
14
WMTWALMART INC
335$492.0M0.43%Put
15
TSLATESLA INC
1,000$205.0M0.18%Put
16
LSTALISATA THERAPEUTICS INC
73,348$136.0M0.12%